Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (251-260 of 527) with videos related to

Pageof 53
Sort By:
The Kaohsiung Journal of Medical Sciences|July 4, 2007
Qualitative application of COBAS AMPLICOR HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0Ming-Yen Hsieh, Li-Po Lee, Nai-Jen Hou, et al.
Journal of Gastroenterology and Hepatology|May 10, 2024
Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver diseaseYi-Ting Chen, Tzu-I Chen, Szu-Ching Yin, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2017
25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacyJee-Fu Huang, Yu-Min Ko, Chung-Feng Huang, et al.
The Journal of Infectious Diseases|January 28, 2010
Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis CChung-Feng Huang, Jeng-Fu Yang, Chia-Yen Dai, et al.
Oncotarget|December 2, 2017
The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinomaChih-Wen Lin, Chih-Che Lin, Po-Huang Lee, et al.
Antiviral Research|April 3, 2007
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis BChia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 6, 2015
Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control studyJen-Eing Jeng, Hui-Fang Wu, Meng-Feng Tsai, et al.
Hepatology Communications|April 13, 2019
Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C InfectionTomi Jun, Yao-Chun Hsu, Shintaro Ogawa, et al.
BMJ Open|May 8, 2019
Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort studyChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|August 31, 2012
Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinomaKiong-Ming Wong, Ming-Lun Yeh, Shih-Chung Chuang, et al.
Pageof 53

Showing results (251-260 of 527) with videos related to

Sort By:
Pageof 53
The Kaohsiung Journal of Medical Sciences|July 4, 2007
Qualitative application of COBAS AMPLICOR HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0Ming-Yen Hsieh, Li-Po Lee, Nai-Jen Hou, et al.
Journal of Gastroenterology and Hepatology|May 10, 2024
Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver diseaseYi-Ting Chen, Tzu-I Chen, Szu-Ching Yin, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2017
25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacyJee-Fu Huang, Yu-Min Ko, Chung-Feng Huang, et al.
The Journal of Infectious Diseases|January 28, 2010
Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis CChung-Feng Huang, Jeng-Fu Yang, Chia-Yen Dai, et al.
Oncotarget|December 2, 2017
The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinomaChih-Wen Lin, Chih-Che Lin, Po-Huang Lee, et al.
Antiviral Research|April 3, 2007
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis BChia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 6, 2015
Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control studyJen-Eing Jeng, Hui-Fang Wu, Meng-Feng Tsai, et al.
Hepatology Communications|April 13, 2019
Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C InfectionTomi Jun, Yao-Chun Hsu, Shintaro Ogawa, et al.
BMJ Open|May 8, 2019
Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort studyChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|August 31, 2012
Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinomaKiong-Ming Wong, Ming-Lun Yeh, Shih-Chung Chuang, et al.
Pageof 53